Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00776308 · ClinicalTrials.gov registry record
Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 98
- Enrollment target
NCT00776308: Completed study, sponsored by Mayo Clinic.
NCT00776308 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 98 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00776308 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 98 participants
- Enrollment target
Study Summary
Conventional mammography is not a reliable method for determining the extent of disease in women with breast cancer. Molecular Breast Imaging (MBI) is a new nuclear medicine technique that allows the breast to be imaged in a manner similar to mammography, but without the pain of compression. Initial results with this method have shown it is very good at detecting small breast cancers (\~1/4 inch). The purpose of this study is to see if MBI is a better method than mammography in determining how much cancer is present before a woman goes to surgery. The study will comprise 120 women with breast cancer who are going to surgery. The investigators hope that this study will demonstrate that MBI will be more accurate in determining how much cancer is present.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00776308
The ClinicalTrials.gov registry entry for NCT00776308 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00776308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00776308 about?
NCT00776308 is a clinical study titled "Use of Molecular Breast Imaging (MBI) to Detect Additional Disease in Women With Breast Cancer Who Are About to go to Surgery". Conventional mammography is not a reliable method for determining the extent of disease in women with breast cancer. Molecular Breast Imaging (MBI) is a new nuclear medicine technique that allows the breast to be imaged in a manner similar to mammography, but without the pain of compression. Initial...
What is the current status of trial NCT00776308?
This trial is currently completed. The enrollment target is 98 participants. The study started on 2008-10. Estimated completion is 2011-02.
Who is sponsoring clinical trial NCT00776308?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.